China · Venture startup

Who invested in Tigermed

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 15 Nov 2026

$7.0Mraised across 2 rounds since 2008, from 2 sources

$5.0MSeries A$2.0MVenture
Latest round
Venture, $2.0MMar 2010
Biggest round
$5.0MSeries A · Jul 2008
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20092010
$5.0MSeries A$2.0MVenture
First round
Series A, $5.0M
Jul 2008
Biggest round
$5.0M
Series A · Jul 2008
Between rounds
19 months
from the last two

The rounds

  1. Mar 2010
    Venture$2.0M1 returning

    From a historical funding record

  2. Jul 2008
    Series A$5.0M1 new

    From a historical funding record

Founders and team

From Tigermed's own website: 1 founder, 2 on the team.

Xiaochun CaoCo-founder, Director, Chair of the Board Executive Committee
  • Meng SongVice President, Chief Technology Officer
  • Hao WuCo-President

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Tigermed

Who invested in Tigermed?

Tigermed's investors include Qiming Venture Partners.

How much has Tigermed raised?

Tigermed has raised $7.0M across 2 rounds since 2008.

When did Tigermed last raise?

Tigermed's most recent round was a Venture of $2.0M in Mar 2010.

What was Tigermed's biggest round?

Tigermed's largest round on record is $5.0M (Series A), in Jul 2008.

Who backed Tigermed first?

Tigermed's first round on record, in Jul 2008, was backed by Qiming Venture Partners.

What stage is Tigermed at?

Tigermed's latest named round is a Venture, in Mar 2010.

Where is Tigermed based?

Tigermed is based in China.

Companies like Tigermed

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.